Your session is about to expire
← Back to Search
Behavioral Intervention
Tele-rehabilitation for Urinary Incontinence
N/A
Waitlist Available
Led By Chantale Dumoulin, PhD
Research Sponsored by Université de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Report no important cognitive deficit (determined with a Mini-Mental State Evaluation (MMSE) score of 24/30 or more)
Have at least three urinary leakage per week, persisting for 3 months or more
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through intervention completion, for 12 weeks
Awards & highlights
Study Summary
This trial will compare a usual care group to a tele-rehabilitation group to see if the treatment is effective when done remotely.
Who is the study for?
This trial is for women aged 65 or older with stress/mixed urinary incontinence, experiencing at least three leakages per week for over three months. Participants must be able to walk independently, understand French or English, have no significant cognitive deficits, and have internet access. Women with certain medical conditions like severe prolapse, chronic constipation, obesity (BMI over 35), or those on UI medication are excluded.Check my eligibility
What is being tested?
The study tests a group pelvic floor muscle training program delivered via tele-rehabilitation to treat urinary incontinence in older women. It aims to see if this online method is feasible and effective compared to traditional face-to-face sessions especially during times when gatherings are restricted.See study design
What are the potential side effects?
Since the intervention involves exercise-based therapy without medications, side effects may include temporary muscle soreness or fatigue from the pelvic floor exercises. No drug-related side effects are expected.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My mental function test score shows no significant cognitive issues.
Select...
I have been experiencing urinary leakage three times a week for at least 3 months.
Select...
I can walk and move around on my own without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through intervention completion, for 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through intervention completion, for 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
number of UI episodes
percentage reduction (%) in the number of UI episodes
Secondary outcome measures
Changes in UI-related quality of life
Changes in bladder, bowel, pelvic organ prolapse and sexual function symptoms and degree to which these symptoms are troubling or bothersome
Changes in urinary symptoms and degree to which UI-associated symptoms are troubling or bothersome
+14 moreOther outcome measures
Cognitive function
Pelvic floor muscle function
Signs and severity of pelvic prolapse
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Group pelvic floor tele-rehabilitationExperimental Treatment1 Intervention
12 weekly treatment online sessions + daily home exercise program
Find a Location
Who is running the clinical trial?
Réseau québécois de recherche sur le vieillissement (RQRV)UNKNOWN
1 Previous Clinical Trials
24 Total Patients Enrolled
Université de MontréalLead Sponsor
213 Previous Clinical Trials
102,689 Total Patients Enrolled
Centre de Recherche de l'Institut Universitaire de Geriatrie de MontrealOTHER
22 Previous Clinical Trials
8,857 Total Patients Enrolled
3 Trials studying Urinary Incontinence
1,531 Patients Enrolled for Urinary Incontinence
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I understand instructions in either French or English.You are very overweight, with a body mass index (BMI) over 35.My mental function test score shows no significant cognitive issues.I have had a urinary or vaginal infection in the last 3 months.I have had treatment for urinary issues or pelvic organ prolapse in the last year.I have been experiencing urinary leakage three times a week for at least 3 months.You have a confirmed pattern of stress or mixed urinary incontinence as shown by the Questionnaire for Incontinence Diagnosis (QUID).I am on medication for urinary incontinence or drugs that affect my muscles.I do not have conditions like severe constipation, major organ prolapse, or serious health issues that could affect pelvic floor muscle training.I can walk and move around on my own without help.I have changed my hormonal replacement therapy in the last 6 months.I am 65 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Group pelvic floor tele-rehabilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants have been enrolled in this experiment?
"Affirmative, according to information presented on clinicaltrials.gov, this research is currently seeking participants. The original posting was made 6th March 2021 and the data has been updated as recently as 21st December 2021. 32 people are desired from a single medical site for enrollment in the trial."
Answered by AI
Is this research program accepting new participants?
"Per clinicaltrials.gov, this research endeavor is presently in the process of recruiting participants. The trial was first published on March 6th 2021 and was most recently revised on December 21st 2021."
Answered by AI
What are the key desired outcomes of this clinical trial?
"The primary outcome of this 12-week clinical trial, measured over a 6 month follow up period will be the percentage reduction in episodes of UI. Secondary outcomes include an evaluation of bladder, bowel, pelvic organ prolapse and sexual function symptoms using the Australian Pelvic Floor Questionnaire (APFQ). Additionally, technology self-efficacy is assessed with the Online Technologies Self-efficacy Scale (OTSES) questionnaire while feasibility/acceptability are evaluated with the System Usability Scale (SUS)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger